The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGEX THERAPEUTICS INC | COM | 00848H108 | 2,038,066 | 2,997,156 | SH | DFND | 1 | 2,997,156 | 0 | 0 | ||
| AXON ENTERPRISE INC | COM | 05464C101 | 151,244,737 | 760,062 | SH | DFND | 1 | 760,062 | 0 | 0 | ||
| ISHARES TR | RUSSELL 2000 ETF | 464287655 | 100,034,840 | 566,000 | SH | DFND | 1 | 566,000 | 0 | 0 | ||
| LINEAGE CELL THERAPEUTICS INC | COM | 53566P109 | 41,223,872 | 34,935,485 | SH | DFND | 1 | 34,935,485 | 0 | 0 | ||
| MONSTER BEVERAGE CORP NEW | COM | 61174X109 | 450,140,446 | 8,501,236 | SH | DFND | 1 | 8,501,236 | 0 | 0 | ||
| ONCOCYTE CORP | COM NEW | 68235C206 | 7,828,286 | 2,509,066 | SH | DFND | 1 | 2,509,066 | 0 | 0 | ||
| STAAR SURGICAL CO | COM PAR $0.01 | 852312305 | 372,244,677 | 9,264,427 | SH | DFND | 1 | 9,264,427 | 0 | 0 | ||